Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2021/06/09
Curator: Madhubani Dey
Revision editor(s): Madhubani Dey, Claregrieve1, WikiWorks, Peace Sandy
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Gestational diabetes diabetes in pregnancy,GDM,gestational diabetes,gestational diabetes mellitus,maternal gestational diabetes mellitus,Gestational diabetes
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Individuals with gestational diabetes
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Individuals with gestational diabetes at third trimester during pregnancy
- Group 0 sample size Number of subjects in the control (unexposed) group
- 31
- Group 1 sample size Number of subjects in the case (exposed) group
- 30
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- 2 weeks
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Mann-Whitney (Wilcoxon)
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- unchanged
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Curated date: 2021/06/27
Curator: Madhubani Dey
Revision editor(s): Madhubani Dey, Claregrieve1, Davvve
Source: Figure 1 D
Description: Differential microbial abundance between individuals diagnosed with gestational diabetes and healthy controls.
Abundance in Group 1: increased abundance in Individuals with gestational diabetes
NCBI | Quality Control | Links |
---|---|---|
Gammaproteobacteria | ||
Haemophilus | ||
Pasteurellaceae | ||
Pasteurellales |
Revision editor(s): Madhubani Dey, Claregrieve1, Davvve
Signature 2
Curated date: 2021/06/27
Curator: Madhubani Dey
Revision editor(s): Madhubani Dey, Claregrieve1, Davvve
Source: Figure 1 D
Description: Differential microbial abundance between individuals diagnosed with gestational diabetes and healthy controls.
Abundance in Group 1: decreased abundance in Individuals with gestational diabetes
NCBI | Quality Control | Links |
---|---|---|
Alistipes | ||
Phascolarctobacterium | ||
Rikenellaceae |
Revision editor(s): Madhubani Dey, Claregrieve1, Davvve
Experiment 2
Curated date: 2021/06/09
Curator: Madhubani Dey
Revision editor(s): Madhubani Dey, Claregrieve1, WikiWorks, Victoria
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Saliva Sailva normalis,Saliva atomaris,Saliva molecularis,Salivary gland secretion,Saliva,saliva
Lab analysis
Statistical Analysis
Alpha Diversity
- Shannon Estimator of species richness and species evenness: more weight on species richness
- unchanged
- Chao1 Abundance-based estimator of species richness
- decreased
- Simpson Estimator of species richness and species evenness: more weight on species evenness
- unchanged
Signature 1
Source: Figure 2D
Description: Differential microbial abundance between individuals diagnosed with gestational diabetes and healthy controls
Abundance in Group 1: increased abundance in Individuals with gestational diabetes
NCBI | Quality Control | Links |
---|---|---|
Bifidobacteriaceae | ||
Bifidobacteriales | ||
Bifidobacterium | ||
Selenomonas |
Revision editor(s): Madhubani Dey, Claregrieve1
Signature 2
Source: Figure 2D
Description: Differential microbial abundance between individuals diagnosed with gestational diabetes and healthy controls
Abundance in Group 1: decreased abundance in Individuals with gestational diabetes
NCBI | Quality Control | Links |
---|---|---|
Fusobacteriota | ||
Fusobacteriaceae | ||
Fusobacteriia | ||
Lachnoanaerobaculum | ||
Lactobacillaceae | ||
Leptotrichia | ||
Leptotrichiaceae | ||
Leuconostoc |
Revision editor(s): Madhubani Dey, Claregrieve1